REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

BioGend Therapeutics Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BioGend Therapeutics Co., Ltd. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

BioGend Therapeutics Co., Ltd. is mainly engaged in the development of bone and cartilage repair. The company was founded in 2016 and is headquartered in New Taipei City, Taiwan.

Headquarters
4F, No.3, Yuang St.Nangang District
Taipei City; Taipei City;

Contact Details: Purchase the BioGend Therapeutics Co., Ltd. report to view the information.

Website: http://www.biogend.com.tw

Basic Information
Total Employees:
Purchase the BioGend Therapeutics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the BioGend Therapeutics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the BioGend Therapeutics Co., Ltd. report to view the information.
Incorporation Date:
July 07, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
30.53%
Purchase this report to view the information.
3.08%
Purchase this report to view the information.
0.66%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Osteopharma Inc. (Japan)
46.73%
Company Performance
Financial values in the chart are available after BioGend Therapeutics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
243.95%▲
Total operating revenue
253.89%▲
Operating profit (EBIT)
14.78%▲
EBITDA
19%▲
Net Profit (Loss) for the Period
16.72%▲
Total assets
25.03%▲
Total equity
27.21%▲
Operating Profit Margin (ROS)
579.28%▲
Net Profit Margin
548.09%▲
Return on Equity (ROE)
6.54%▲
Quick Ratio
9.51%▲
Cash Ratio
9.43%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
PharmaEssentia Corp.
 
Pharmally International Holding Co., Ltd
Formosa Pharmaceuticals, Inc.
 
Glyconex Incorporation
Innopharmax Inc.
 
U-Neuron Biomedical Inc.
Lumosa Therapeutics Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo